Navigation Links
Adeona to Host Investor Day on Zinc Deficiency in Alzheimer's Disease
Date:1/18/2011

long the Briarwood Shopping Mall circle, only 2.5 miles from downtown Ann Arbor and the University of Michigan, and 25 miles from Detroit Metropolitan Airport. The hotel address is: 610 Hilton Blvd., Ann Arbor, MI. 48108.

About Adeona Pharmaceuticals, Inc.

Adeona is a pharmaceutical company developing innovative medicines for the treatment of serious central nervous system diseases. The Company's strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Currently, Adeona is developing the following product candidates: a prescription medical food for Alzheimer's disease, and drugs for multiple sclerosis, fibromyalgia, rheumatoid arthritis and age-related macular degeneration. For more information, please visit Adeona's website at www.adeonapharma.com.

This release includes forward-looking statements on Adeona's current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the timing and results of our clinical study and our ability to successfully develop products with superior benefits. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, a failure of our clinical 
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Adeona to Present at OneMedForum San Francisco 2011 Conference
2. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
3. Adeona Announces Third Quarter 2010 Financial Results and Achievements
4. Adeona to Hold Annual Shareholder Meeting
5. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
6. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
7. Adeona Announces Second Quarter 2010 Profitability and Achievements
8. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
9. Adeona Announces HartLab Expansion Into Microbiology Testing Services
10. NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011
11. Watson to Host Investor Day on January 21 in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Ambit Biosciences (Nasdaq: AMBI ), a biopharmaceutical company ... in oncology, autoimmune and inflammatory disease, today announced the Company,s ... held at The New York Palace Hotel in ... Alan Fuhrman , Ambit,s CFO, will provide an ... at 1:10 p.m. ET on Wednesday, September 3, 2014.  The ...
(Date:8/27/2014)... Aug. 27, 2014  After the February 2014 launch ... billing solution for medical practices and management companies, ... the new software. "The feedback has been ... . "The sheer number of demos and new sign-ups ... was for these types of software features." ...
(Date:8/27/2014)... , Aug. 27, 2014  Zimmer Holdings, Inc. (NYSE ... announced that it will be participating in the Morgan ... in New York, New York , ... President and CEO of Zimmer, will be presenting at ... and CEO of Biomet, will join Mr. Dvorak for ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
... PHILADELPHIA, Oct. 5 GlaxoSmithKline [NYSE: GSK] today ... Administration,s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted ... (pazopanib). Specifically, the panel voted that the benefit-to-risk ... cell carcinoma (RCC). Pazopanib is an investigational, oral ...
... PALO ALTO, Calif., Oct. 5 PEAK Surgical, Inc. ... an agreement that grants the Surgical Technologies business at ... the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection ... , "PEAK,s agreement with Medtronic is a major ...
Cached Medicine Technology:GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 2GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM) 3PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market 3
(Date:8/27/2014)... 2014 Power morcellator lawsuits ( http://www.gynecaremorcellatorlawsuit.com/ ... behalf of women who allegedly experienced the spread of ... reports. According to court documents, one of the most ... U.S. District Court, Northern District of New York, on ... of a power morcellator manufactured Karl Storz Endoscopy - ...
(Date:8/27/2014)... What’s next for 14 year old Sriram Hathwar, ... Spelling Bee? Sririam will visit Philadelphia on Friday, August ... Eye Hospital.     , The teen from Painted Post, New ... , Wills Eye Ophthalmologist-in-Chief, Dr. Julia Haller will show ... diagnostic testing. He will also tour historic Philadelphia ...
(Date:8/27/2014)... The newest Abington Health Center ... 8, 2014. This new 15,000 square foot, $5 million ... care practices and walk-in laboratory services. , ... endeavor for Abington Health as the healthcare landscape changes,” ... “Establishing a location in Lower Gwynedd allows us to ...
(Date:8/27/2014)... -- Overconfident people are better at convincing others that ... are more likely to get promotions and reach high-level ... that these "self-deceived" people are also more likely to ... And finally, people who underestimate themselves are regarded ... British researchers. Their findings were published Aug. 27 in ...
(Date:8/27/2014)... Recent growth in health care spending for commercially ... for medical services, rather than increased use, according to ... Institute for Health Policy & Clinical Practice, published in ... Managed Care . , There is increasing concern that ... increased prices faced by payers and, ultimately, consumers," said ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:Abington Health Opens New Health Center in Lower Gwynedd 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Tracking spending among the commercially insured 2
... Lancet Neurology says that the fact that first-borns have a ... myth. Birth order of the children does not increase their ... // have any affect on the incidence of multiple sclerosis., ... a role in MS. Previous research has reported a higher ...
... A new study indicates that a combination of surgery ... patients suffering from spinal cord compression. //, ,Metastatic ... common complication of cancer, occurring in 5 to 14 ... of corticosteroids and radiotherapy - after which only 50 ...
... also been under intense scrutiny to look at their ... and 25 other related conditions) and HIV. // , ... lover of all, Casanova in the 17th century was ... against infection. The question now is that how much ...
... the genetic pathway involved in the development of hearing. Research ... ear –– the cells largely responsible for hearing // ... ,Situated in the hearing portion of the inner ... the ear in the form of sound waves into chemical ...
... claimed at least 20 lives in the past two weeks ... already present in the neighboring Indian state of UP // ... 10 deaths each in the townships of Tikapur and Dhangadi ... 80 patients were undergoing treatment in various hospitals and health ...
... slowly spreading in UP and causing more deaths especially in ... caused by the rapidly spreading killer virus // in ... disease was so far confined largely to Gorakhpur and neighboring ... only nearby Bahraich, Barabanki and Lakhimpur-Kheri districts but also to ...
Cached Medicine News:Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 3Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 4Health News:Encephalitis Claims 131 lives in Uttar Pradesh 2
Liquichek Pediatric Control is a product designed to monitor important analytes for neonatal testing. This control monitors four bilirubin parameters at two clinically significant levels....
... Chemistry Control (Human) provides a comprehensive ... enzymes and CO2. It requires no ... most major instruments and methodologies. Available ... fill sizes (10 mL fill size ...
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Lyphochek® Drug Free Serum can serve as a drug-free baseline for HPLC analysis or as a negative control....
Medicine Products: